Last reviewed · How we verify
NCT06743425: RAMP
A Pilot Study of a Remote ADHD Monitoring Program
NA trial testing RAMP Reports in Attention-deficit/Hyperactivity Disorder in 36 participants. Currently enrolling.
23 February 2026
Quick facts
| Lead sponsor | IDeA States Pediatric Clinical Trials Network |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 36 |
| Start date | 4 February 2025 |
| Primary completion | 23 February 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- RAMP Reports
- Digital Education Handouts
Conditions studied
- Attention-deficit/Hyperactivity Disorder — all drugs for Attention-deficit/Hyperactivity Disorder →
- ADHD — all drugs for ADHD →
Sponsor
IDeA States Pediatric Clinical Trials Network
Who can join
Adults 5 to 11, any sex, with Attention-deficit/Hyperactivity Disorder or ADHD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver/infant dyads across 2 sites and will evaluate feasibility endpoints rather than clinical outcomes. Enrolled participants will be randomized 1:1 to the intervention group (RAMP reports) or control group (digital education handouts). The study duration is 10 months, including start-up, enrollment and intervention, and data analysis and manuscript submission.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Study protocol for a pilot study for Remote ADHD Monitoring Program (RAMP) for children in rural areas.
MacGeorge CA, Henry M, Ford HA, Malloch L, et al · · 2025 · PMID 41329787 · DOI 10.1371/journal.pone.0337802
Verify or expand the search:
- PubMed search for NCT06743425
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Attention-deficit/Hyperactivity Disorder
Currently open trials in the same condition.
- NCT06376331 — Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder · Phase 1 · recruiting
Other IDeA States Pediatric Clinical Trials Network trials
Trials by the same sponsor.
- NCT06423664 — Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure · NA · recruiting
- NCT06479278 — Talk With Me Baby to Enhance the Early Home Language Environment · NA · recruiting
- NCT05994183 — The Bronchiolitis in Hospitalized Infants Study · EARLY_PHASE1 · withdrawn
- NCT05615870 — Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters · NA · completed
- NCT05386355 — Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06743425 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IDeA States Pediatric Clinical Trials Network
- Last refreshed: 24 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06743425.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing